Anemia during pregnancy remains a significant public health issue that requires diligent monitoring by clinicians. A recent longitudinal study in a nationwide cohort analyzed hemoglobin and hematocrit values across different gestations. The findings reveal that the overall prevalence of this condition reached 25.6%. Specifically, the study highlights how prevalence shifts dramatically from early to mid-pregnancy. Consequently, understanding these patterns is vital for improving maternal and perinatal health outcomes.

Researchers identified a sharp increase in cases as pregnancies progressed. While only 4.3% of individuals had anemia at the initiation of prenatal care, this figure climbed to 24.5% during the second trimester. Furthermore, this trend suggests that routine screening must be robust throughout the middle stages of gestation. Moreover, the study utilized trimester-specific standards to ensure high sensitivity in diagnosis. Therefore, healthcare providers should remain vigilant even if early laboratory results appear normal.

Clinical Risks Associated with Anemia during pregnancy

Untreated iron deficiency leads to several adverse outcomes for both the mother and the infant. For instance, it significantly increases the risk of preterm birth and low birth weight. Additionally, maternal complications such as severe fatigue and postpartum hemorrhage occur more frequently in affected individuals. In the Indian context, where the prevalence of anemia is even higher than in Western cohorts, these findings underscore the urgency of early intervention. Consequently, clinicians must prioritize iron supplementation and nutritional counseling to safeguard maternal health.

Frequently Asked Questions

How common is anemia during pregnancy?

According to recent nationwide data, approximately 25.6% of pregnant individuals experience anemia. However, this prevalence is notably higher in some regions, such as India, where public health surveys indicate that more than half of all pregnant women are affected by the condition.

Why is mid-pregnancy screening for anemia during pregnancy so important?

Screening during the second trimester is critical because blood volume expands rapidly to support the fetus. This physiological change often leads to a drop in hemoglobin levels. Consequently, individuals who were non-anemic in the first trimester may develop the condition by 22 to 30 weeks of gestation.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship between the reader and the author. While we strive for accuracy, medical knowledge is constantly evolving. Refer to the latest local and national guidelines for clinical practice.

References

1. Igbinosa II et al. Anemia During Pregnancy in a U.S. Nationwide Cohort, 2018-2023. Obstet Gynecol. 2026 Mar 26. doi: 10.1097/AOG.0000000000006270. PMID: 41886759.


2. Ministry of Health and Family Welfare, Government of India. National Family Health Survey (NFHS-5), 2019-21.


3. World Health Organization (WHO). Anaemia in women and children: Global prevalence and management guidelines.